Celldex Therapeutics
CLDX
#4622
Rank
ยฃ1.64 B
Marketcap
ยฃ20.95
Share price
-1.93%
Change (1 day)
10.02%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): -ยฃ3.26

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ3.32. In 2025 the company made an earnings per share (EPS) of -ยฃ2.97 a decrease over its 2024 EPS that were of -ยฃ1.87.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ3.269.59%
2025-ยฃ2.9758.78%
2024-ยฃ1.87
2022-ยฃ1.8345.73%
2021-ยฃ1.25-23.36%
2020-ยฃ1.64-41.05%
2019-ยฃ2.77-76.95%
2018-ยฃ12.04
2016-ยฃ14.44-3.82%
2015-ยฃ15.02-0.76%
2014-ยฃ15.13
2012-ยฃ11.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ13.28-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.20-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-ยฃ3.35 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-ยฃ3.06-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ1.54-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ3.85 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA